<?xml version="1.0" encoding="UTF-8"?>
<ref id="B89">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Nielsen</surname>
    <given-names>C. A. F.</given-names>
   </name>
   <name>
    <surname>Folly</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Hatsch</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Molt</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Schröder</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>O’Connor</surname>
    <given-names>S. E.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2014</year>). 
  <article-title>The important ergot alkaloid intermediate chanoclavine-I produced in the yeast 
   <italic>Saccharomyces cerevisiae</italic> by the combined action of EasC and EasE from aspergillus japonicus.
  </article-title>
  <source>
   <italic>Microb. Cell Fact.</italic>
  </source>
  <volume>13</volume>:
  <issue>95</issue>. 
  <pub-id pub-id-type="doi">10.1186/s12934-014-0095-2</pub-id>
  <?supplied-pmid 25112180?>
  <pub-id pub-id-type="pmid">25112180</pub-id>
 </mixed-citation>
</ref>
